Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 556741 - 556760 out of 557914 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 20MG/0.4ML INJ,SYRINGE,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 20MG/0.4ML INJ,SYRINGE,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PSORIASIS-UVEITIS | 4X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PSORIASIS-UVEITIS | 4X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,SYRINGE,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,SYRINGE,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.8ML INJ,PEN,PSORIASIS | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.8ML INJ,PEN,PSORIASIS | 6 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.8ML INJ,PEN,PSORIASIS | 4 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.8ML INJ,PEN,PSORIASIS | 6 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.8ML INJ,PEN,PSORIASIS | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.8ML INJ,PEN,PSORIASIS | 4 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.8ML INJ,SYRINGE,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.8ML INJ,SYRINGE,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO(CF) 40MG/0.4ML INJ,PEN,CROHN-UC-H | 6X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO(CF) 40MG/0.4ML INJ,PEN,CROHN-UC-H | 6X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AC02) basiliximab (adm: P, course dose) | SIMULECT 10MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | NovartisPharmaceuticalsCorporation |
| USA | (L04AC02) basiliximab (adm: P, course dose) | SIMULECT 10MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | NovartisPharmaceuticalsCorporation |
Pages
